Skip to main content

Table 2 Univariate and multivariate cox regression for prostate cancer incidence among overall patients

From: The effect of subsequent immunosuppressant use in organ-transplanted patients on prostate cancer incidence: a retrospective analysis using the Korean National Health Insurance Database

Characteristics

N

Event

Duration

IR (per 1000)

Univariate

Multivariate

HR

p value

HR

p value

Age (years), 20 ≤ Age < 50

25,856

18

135,209.95

0.1331

0.098 (0.06,0.161)

< .0001

0.113 (0.069,0.186)

< .0001

 50 ≤ Age < 65

24,308

144

110,258.86

1.306

1 (Ref.)

 

1 (Ref.)

 

 65 ≤ Age ≤ 75

1688

25

6550.21

3.8167

3.089 (2.019, 4.726)

 

2.995 (1.948,4.603)

 

 75 < Age

28

1

76.54

13.0646

12.92 (1.803,92.597)

 

13.851 (1.918,100.017)

 

Aspirin

1776

13

8017.85

1.62138

2.3 (1.309,4.04)

0.0038

1.295 (0.722,2.324)

0.3863

Statin

8701

37

39,075.1

0.94689

1.364 (0.952,1.955)

0.0905

1.32 (0.774,2.254)

0.3082

Duration of Immunosuppressant agent (> 300 days)

11,338

78

57,837.55

1.3486

2.345 (1.754,3.134)

 < 0.001

3.504 (1.345,9.129)

0.0084

Hypertension

15,511

80

72,050.92

1.11033

1.878 (1.407,2.508)

 < 0.001

1.347 (0.971,1.87)

0.0746

Diabetes mellitus

9504

64

44,114.7

1.45076

2.461 (1.82,3.328)

 < 0.001

1.198 (0.839,1.71)

0.3202

Dyslipidemia

8546

29

37,485.7

0.77363

1.073 (0.722,1.595)

0.7258

0.632 (0.353,1.131)

0.122

Transplanted organ

        

 Control

38,910

111

190,764.2

0.58187

1 (Ref.)

 < .0001

1 (Ref.)

0.0271

 1. Kidney

7026

21

33,615.34

0.62471

1.08 (0.677,1.722)

 

0.319 (0.11,0.922)

 

 2. Liver

5445

54

25,616.58

2.10801

3.661 (2.645,5.068)

 

0.838 (0.314,2.24)

 

 3. Pancreas

28

0

105.38

0

N.A

 

N.A

 

 4. Heart

398

2

1760.07

1.13632

2.013 (0.497,8.151)

 

0.37 (0.068,2.03)

 

 5. Lung

73

0

233.99

0

N.A

 

N.A

 
  1. N.A not available